Text and Data Mining valid from 2018-03-01
Received: 26 March 2017
Accepted: 8 February 2018
First Online: 19 March 2018
: EMBL has filed two patent applications on repurposing compounds identified in this study for the treatment of infections and for modulating the composition of the gut microbiome, and on the use of the <i>in vitro</i> model of the human gut microbiome to study the impact of xenobiotics (Tentative European patent application numbers EP 18156520 and EP 18155278, respectively). Authors L.M., M.P., M.K., G.Z., K.R.P., P.B. and A.T. are listed as inventors.